The Swiss voice in the world since 1935
Top stories
Stay in touch with Switzerland

Vaccination may protect against severe Covid-19 for 3 years

vaccination
The task force estimates that mRNA vaccination provides more immunity to severe Covid-19 than natural infection. Keystone / Laurent Gillieron

Swiss immunology experts estimate mRNA vaccination could provide more than two times the length of protection against severe Covid-19 infection than natural infection.

In a policyExternal link brief published on Friday, the Swiss National Covid Science Task Force writes that after mRNA vaccination, individuals below 65 years of age likely maintain more than 50% protection against mild infection for 16 months or longer and more than 80% protection against severe infection for more than three years.

This is 3-6 months and 10-12 months more than after natural infection. For the same age group, the scientists estimate that there is 16 months protection from severe disease after natural infection.

In people over 70 years old, the protection is expected to be shorter. The scientists estimate that protection against severe infection may last for up to 2 years.

The estimates use data modelling based on recent scientific evidence on B and T cell responses after vaccination or infection.

The authors caution that these are preliminary estimates that rely on several assumptions and extrapolations of existing data. A true immunologic correlation of protection from SARS-CoV-2 infection has not been identified. The findings may also not be accurate in the face of highly transmissible variants. “Protection against such variants is predicted to be significantly lower and shorter lived,” write the authors.

The protection duration can help inform when booster shots should be given and the length of validity for Covid-19 certificates. Based on the findings, a booster shot for lower risk individuals may not be necessary within two years. For people over 70 years old, a booster may offer benefits if administered within one year.

The scientists also recommend that the sequencing of viral variants is accompanied by monitoring of risk groups for premature reductions in immunity to severe infection.

Popular Stories

Most Discussed

News

'Leopard 1 A5' combat tanks in Germany.

More

Switzerland eyes joining EU rearmament programme

This content was published on The Federal Council wants to explore the possibilities of joining the European Union’s €800-billion rearmament programme without compromising Swiss neutrality.

Read more: Switzerland eyes joining EU rearmament programme
Premiere for Swiss Air Force on French National Day

More

Premiere for Swiss Air Force on French National Day

This content was published on On July 14, the Swiss Air Force will take part in the traditional air parade in Paris to mark the French bank holidays with an F/A-18 fighter jet. This is a first for Switzerland.

Read more: Premiere for Swiss Air Force on French National Day
Industry calls for "lean implementation" of the EU treaty package

More

Swiss industry backs EU treaty package

This content was published on The Swiss business umbrella organisation Economiesuisse and the employers' association broadly support the package of agreements negotiated with the European Union.

Read more: Swiss industry backs EU treaty package

In compliance with the JTI standards

More: SWI swissinfo.ch certified by the Journalism Trust Initiative

You can find an overview of ongoing debates with our journalists here . Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.

SWI swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR

SWI swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR